Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	42,093	30,350	24,021	29,238	20,282	15,100	Upgrade
Market Cap Growth	85.71%	26.35%	-17.84%	44.16%	34.32%	17.60%	Upgrade
Enterprise Value	42,183	30,296	24,278	29,564	19,873	14,639	Upgrade
Last Close Price	312.32	235.31	191.41	237.65	169.58	129.97	Upgrade
PS Ratio	17.10	13.50	13.14	28.18	24.02	30.64	Upgrade
PB Ratio	364.65	452.40	-108.87	-184.79	34.48	14.86	Upgrade
P/TBV Ratio	364.65	452.40	-	-	34.48	14.86	Upgrade
P/FCF Ratio	-	-	572.67	-	-	-	Upgrade
P/OCF Ratio	-	-	230.62	-	-	-	Upgrade
EV/Sales Ratio	17.96	13.48	13.28	28.50	23.54	29.70	Upgrade
EV/FCF Ratio	-	-	578.81	-	-	-	Upgrade
Debt / Equity Ratio	23.58	40.89	-12.16	-16.51	3.72	1.57	Upgrade
Debt / FCF Ratio	-	-	63.96	-	-	-	Upgrade
Asset Turnover	0.58	0.56	0.50	0.29	0.24	0.17	Upgrade
Inventory Turnover	4.12	3.86	2.85	1.57	1.74	1.19	Upgrade
Quick Ratio	2.84	2.61	2.86	3.17	3.79	4.23	Upgrade
Current Ratio	3.04	2.78	3.08	3.51	4.04	4.47	Upgrade
Return on Equity (ROE)	-	-	-	-526.14%	-106.31%	-69.92%	Upgrade
Return on Assets (ROA)	-1.79%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%	Upgrade
Return on Capital (ROIC)	-2.72%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%	Upgrade
Earnings Yield	-0.64%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%	Upgrade
FCF Yield	-0.18%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%	Upgrade
Buyback Yield / Dilution	-2.49%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%	Upgrade

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q